MBM Wealth Consultants’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
MBM Wealth Consultants's EW Position: Q2 2026 in Review
MBM Wealth Consultants sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 78 shares — an estimated $6.25K sold.
MBM Wealth Consultants first reported a position in EW in Q4 2018 and held it in 19 quarters. The position peaked at $648K in Q1 2022. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- MBM Wealth Consultants reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
- MBM Wealth Consultants sold 78 Edwards Lifesciences shares in Q2 2026, an estimated $6.25K.
- MBM Wealth Consultants first reported a position in Edwards Lifesciences in Q4 2018 and held it in 19 quarters.
- MBM Wealth Consultants's Edwards Lifesciences position peaked at $648K in Q1 2022.
- 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on MBM Wealth Consultants's 13F filing for Q2 2026, filed 24 Jul 2026.